Fundz

Who to call at Adaptive Biotechnologies Corporation, and when

Fundz watches for the moments Adaptive Biotechnologies Corporation starts buying, and tells you who to reach.

  • An alert the day Adaptive Biotechnologies Corporation raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Adaptive Biotechnologies Corporation, from your own LinkedIn network
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Adaptive and Rapid Addition Announce Partnership for Best-in-class FIX Capabilities

Feb 04, 2025

Contract Type

partnership

SeattleBiotechnologyHealth CareTherapeutics

Description

Adaptive and Rapid Addition have announced a partnership to deliver best-in-class FIX capabilities to capital markets firms. The partnership will enable Adaptive to provide comprehensive counterparty connectivity and order management workflow within their custom trading technology platforms, leveraging Rapid Addition’s scalable FIX platform.

Company Information

Company

Adaptive Biotechnologies Corporation

Location

Seattle, Washington, United States

About

Adaptive Biotechnologies is a commercial-stage biotechnology company focused on harnessing the adaptive immune system's biology to transform disease diagnosis and treatment. They develop clinical products aimed at diagnosing and treating diseases using advanced genetic techniques. Their flagship product, clonoSEQ®, is designed to detect minimal residual disease in various blood cancers. The company's innovative approach seeks to provide precise and effective solutions in the field of hematology.

Related People

Francis
Senior decision-maker at this company
••••••••@••••••••

See Francis's verified email →

Create an account to reveal verified emails
Predictive Intelligence
Strategic

ML-powered predictions for Adaptive Biotechnologies Corporation's next move

Learn about Strategic plan

Agreement Insights

What this usually means
Strategic partnership established
Partnership agreements typically involve technology integration and joint go-to-market strategies

Adaptive Biotechnologies Corporation signed a new agreement. Fundz surfaces partnerships and contracts as they are announced.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.